Supplementary Material for: Direct Interaction of α-Synuclein and AKT Regulates IGF-1 Signaling: Implication of Parkinson Disease
Chung J.-Y.
Lee S.-J.
Lee S.-H.
Jung Y.S.
Ha N.-C.
Seol W.
Park B.-J.
10.6084/m9.figshare.5121766.v1
https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Direct_Interaction_of_-Synuclein_and_AKT_Regulates_IGF-1_Signaling_Implication_of_Parkinson_Disease/5121766
Genetic mutation of α-synuclein (α-SYN) is clearly verified as the causal factor of human and mouse Parkinson’s disease. However, biological function of α-SYN has not been clearly demonstrated until now. In this investigation, we reveal that α-SYN is a co-regulator of growth factor-induced AKT activation. Elimination of SYN reduces the IGF-1-mediated AKT activation. Similarly, mutant SYN suppresses the IGF-1-induced AKT activation. Wild-type SYN can interact with AKT and enhance the solubility and plasma localization of AKT in response to IGF-1, whereas mutant α-SYNs do not interact with AKT. In addition, elevated expression of SYN blocks the AKT activation. We also find that si-RNA against α-SYN abolished the protective effect of IGF-1 against DNA damage-induced apoptosis. Our result strongly indicates that Parkinson’s disease, induced by α-SYN mutation, is evoked by deregulation of the AKT-signaling cascade.
2011-04-08 00:00:00
α-Synuclein
AKT
Parkinsonߣs disease
IGF-1 signaling